Sherwin-Williams Treasury Stock increased by 739.6% to $707.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 90.4%, from $7.36B to $707.80M. Over 5 years (FY 2020 to FY 2025), Treasury Stock shows a downward trend with a -2.7% CAGR.
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
treasury_stock| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.87B | $3.78B | $4.10B | $4.34B | $4.75B | $5.23B | $5.79B | $6.23B | $6.68B | $6.99B | $7.36B | $7.88B | $8.55B | $84.30M | $707.80M |
| QoQ Change | — | +31.6% | +8.6% | +5.7% | +9.5% | +10.3% | +10.7% | +7.5% | +7.2% | +4.7% | +5.3% | +7.0% | +8.5% | -99.0% | +739.6% |
| YoY Change | — | +31.6% | — | — | — | +38.6% | +41.3% | +43.7% | +40.7% | +33.5% | +27.1% | +26.5% | +28.0% | -98.8% | -90.4% |